HSPA5 and osteosarcoma: Studies have shown that GRP78 expression is enhanced in osteosarcoma tissues of patients resistant to both doxorubicin and platinum-based drugs, suggesting that GRP78 is involved in ERS-induced drug resistance in osteosarcoma cells.